Managed Health Care

Humana

Humana Secures $1.5 Billion Financing Agreement to Issue Senior Notes

Humana Reports Q1 Revenue Growth but Profit Slump and Acquires MaxHealth

Humana Reports Better-than-Expected Q1 Earnings with Lower-than-Expected Claim Ratio

Humana released FY2026 Q1 earnings on April 29 Pre-Market (EST), actual revenue USD 39.65 B (forecast USD 39.39 B), actual EPS USD 9.83 (forecast USD 10.7501)

Humana's Q1 Profit Exceeds Expectations

Humana Sees Full-Year EPS Outlook at $8.36

Humana to Release FY2026 Q1 Earnings on April 29 Pre-Market EST, Forecast Revenue USD 39.39 B, EPS USD 10.4345

Humana Publishes Inhaler Education Program Study

Wells Fargo Upgrades Humana's Rating and Raises Target Price

Humana Announces Cost-Saving Measures

Humana Prices $1 Billion of Senior Notes Due in 2056

Humana Prices 1 Billion USD Senior Unsecured Notes Offering

Humana Inc. Announces Strengthening of Heart Disease Care Program

Humana Reaffirms 2026 Fiscal Year Earnings Guidance

CenterWell's CEO Sanjay K. Shetty Acquires Shares of Humana Inc.

Humana Reports Significant Premium and Revenue Growth for Fiscal Year 2025

Humana Reports Earnings and Revenue Beat, Updates 2026 Guidance

Humana Reports Widening Loss in Q4

Humana released FY2025 Annual Earnings on February 11, Pre-Market EST, with forecast revenue USD 129.23 B and forecast EPS USD 12.5077

Humana released FY2025 Q4 earnings on February 11 Pre-Market (EST), actual revenue USD 32.52 B (forecast USD 32.01 B), actual EPS USD -6.6146 (forecast USD -4.076)

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

Humana Inc. (HUM.US) Q3 2025 Earnings Conference Call

Humana Inc. (HUM.US) Q1 2025 Earnings Conference Call

Humana Inc. (HUM.US) Q4 2024 Earnings Conference Call

Humana Inc. (HUM.US) Q3 2024 Earnings Conference Call

Zacks Research upgraded Humana (NYSE:HUM) from a 'strong sell' to a 'hold' rating. They provided earnings estimates for 2026 and 2027, with FY2026 earnings projected at $9.01 EPS. Several analysts have raised their price targets for Humana, with an average target of $246.83. Humana's stock opened at $300.52, with a market cap of $36.08 billion. The company reported $10.31 EPS for the last quarter, exceeding estimates, and revenue increased by 23.5% year-over-year.

Market Beat

VG Health

Health Care Select Sector SPDR

SPDR S&P Health

iShares US Healthcare Providers

Jefferies Financial

Oppenheimer

Mizuho Financial

UBS Group AG

Unitedhealth

Mizuho Financial Group, Inc.

Humana (NYSE:HUM) Upgraded by Zacks Research to Hold Rating

Humana Stock Outlook: Is Wall Street Bullish or Bearish?

Barchart Option

Humana Stock Outlook: Is Wall Street Bullish or Bearish?

Humana Inc.'s stock price target has been raised to $246.46, suggesting an 18% downside based on the May 14 closing price. The consensus rating remains a 'Hold' from 29 analysts, with 7 Buys, 20 Holds, and 2 Sells. Estimates from 24 analysts show a price target range of $180 to $290 per share.

TradingView

Factset Research

Humana Inc. Stock 12‑Month Price Target Raised to $246.46, Implies 18% Downside

Humana Inc. (HUM) shares fell 1.15% to $301.35 on Thursday, underperforming against competitors despite a strong overall market, with the S&P 500 up 0.77%. This decline ended a two-day winning streak, leaving the stock 4.44% below its 52-week high of $315.35. Competitors like UnitedHealth Group and Elevance Health also saw declines, while Chubb Ltd. rose 1.29%. Trading volume was 2.0 million, surpassing the 50-day average of 1.8 million.

MarketWatch Automated

S&P 500

Dow Jones Industrial Average

Elevance Health

Chubb

Humana Inc. Stock Underperforms Thursday When Compared To Competitors

Zacks Research has issued a negative outlook for Humana Inc. (NYSE:HUM), lowering its Q1 2027 earnings per share estimate from $8.98 to $8.69, maintaining a "Strong Sell" rating. The consensus for the full-year earnings is $9.06 per share. Various analysts have adjusted their price targets for Humana, with an average target price of $246.83. Humana's stock opened at $305.08, with a market cap of $36.63 billion. The company recently declared a quarterly dividend of $0.885, with a yield of 1.2%.

Zacks Research Issues Negative Outlook for Humana Earnings

Humana, CenterWell and USAA Unite with VFW for National Day of Service Supporting Veterans Experiencing Homelessness | HUM Stock News

StockTitan

Humana, CenterWell and USAA Unite with VFW for National Day of Service Supporting Veterans Experiencing Homelessness | HUM Stock News

Humana Inc. (HUM) shares rose 3.22% to $304.85 on a mixed trading day, outperforming competitors like UnitedHealth Group (UNH) and Elevance Health (ELV). The S&P 500 Index increased by 0.58%, while the Dow Jones fell by 0.14%. Humana's stock is 3.33% below its 52-week high of $315.35, achieved on September 5th. Trading volume reached 3.1 million, surpassing the 50-day average of 1.8 million.

Humana Inc. Stock Outperforms Competitors On Strong Trading Day

Humana(HUM.US)

Humana (NYSE:HUM) Upgraded by Zacks Research to Hold Rating

Humana Stock Outlook: Is Wall Street Bullish or Bearish?

Humana Inc. Stock 12‑Month Price Target Raised to $246.46, Implies 18% Downside

Humana Inc. Stock Underperforms Thursday When Compared To Competitors

Zacks Research Issues Negative Outlook for Humana Earnings

Humana, CenterWell and USAA Unite with VFW for National Day of Service Supporting Veterans Experiencing Homelessness | HUM Stock News

Humana Inc. Stock Outperforms Competitors On Strong Trading Day